Journal of Nuclear Cardiology

, Volume 16, Issue 5, pp 801–810

Effectiveness of prolonged fasting 18f-FDG PET-CT in the detection of cardiac sarcoidosis

  • Rumman Langah
  • Kenneth Spicer
  • Mulugeta Gebregziabher
  • Leonie Gordon
Original Article

Abstract

Background

The Japanese Ministry of Health and Welfare guidelines (JMHWG) are currently the standard used to diagnose cardiac sarcoidosis. JMHWG incorporate 67Gallium scintigraphy as a minor criterion, while fasting 18fluorine-2-fluro-2-deoxy-d-glucose (FDG) PET is not included. As there is no published data comparing the accuracy of prolonged fasting FDG PET-CT (PF-PET) and Gallium scintigraphy for detecting active cardiac sarcoidosis, we sought to compare these two modalities.

Methods and Results

We retrospectively reviewed medical records and nuclear images of 76 patients with suspected cardiac sarcoid who had either PF-PET or Gallium scintigraphy between January 2004 and August 2008. Eleven patients were excluded due to inadequate fasting for PF-PET, incomplete records or diagnosis other than sarcoid. Cardiac catheterizations, electrocardiogram interpretations, echocardiography reports, pathology reports, therapeutic interventions, and follow-up findings were correlated to PF-PET and Gallium scintigraphy results. Nuclear images of all patients including controls were reviewed independently by two experienced nuclear physicians blinded to results. Using JMHWG as reference standard, sensitivity, specificity, and accuracy of PF-PET were 85%, 90%, and 86.7% and for Gallium scintigraphy were 15%, 80%, and 42.8%.

Conclusions

Relative to Gallium scintigraphy, PF-PET appears to provide greater accuracy for detecting cardiac sarcoidosis. Our findings also highlight the importance of revising JMHWG to incorporate PF-PET and the importance of adequate prolonged fasting prior to FDG PET imaging.

Keywords

PET/CT imaging metabolism PET fluorodeoxyglucose (FDG) cardiomyopathy inflammation 

References

  1. 1.
    Habersberger J, Manins V, Taylor AJ. Cardiac sarcoidosis. Intern Med J 2008;38(4):270-7.PubMedCrossRefGoogle Scholar
  2. 2.
    Bargout R, Kelly RF. Sarcoid heart disease: Clinical course and treatment. Review Int J Cardiol 2004;97:173-82.CrossRefGoogle Scholar
  3. 3.
    Hiraga H, Yuwai K, Hiroe M, et al. Guideline for diagnosis of cardiac sarcoidosis: Study report on diffuse pulmonary diseases from Japanese Ministry of Health and Welfare, vol. 6. Tokyo: Japanese Ministry of Health and Welfare; 1993. p. 23-4.Google Scholar
  4. 4.
    Eguchi M, Tsuchihashi K, Hotta D, et al. Technetium-99m sestamibi/tetrofosmin myocardial perfusion scanning in cardiac and noncardiac sarcoidosis. Cardiology 2000;94(3):193-9.PubMedCrossRefGoogle Scholar
  5. 5.
    Ding HJ, Shiau YC, Wang JJ, Ho ST, Kao A. The influences of blood glucose and duration of fasting on myocardial glucose uptake of [18F]fluoro-2-deoxy-d-glucose. Nucl Med Commun 2002;23(10):961-5.PubMedCrossRefGoogle Scholar
  6. 6.
    Okumura W, Iwasaki T, Toyama T, et al. Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis. J Nucl Med 2004;45(12):1989-98.PubMedGoogle Scholar
  7. 7.
    Bleeker-Rovers CP, Vos FJ, Mudde AH, et al. A prospective multi-centre study of the value of FDG-PET as part of a structured diagnostic protocol in patients with fever of unknown origin. Eur J Nucl Med Mol Imag 2007;34(5):694-703. Epub 2006 Dec 14.CrossRefGoogle Scholar
  8. 8.
    Kaim AH, Weber B, Kurrer MO, Gottschalk J, Von Schulthess GK, Buck A. Autoradiographic quantification of 18F-FDG uptake in experimental soft-tissue abscesses in rats. Radiology 2002;223(2):446-51.PubMedCrossRefGoogle Scholar
  9. 9.
    Tsan MF, Scheffel U. Mechanism of gallium-67 accumulation in tumors. J Nucl Med 1988;29(12):2019-20.PubMedGoogle Scholar
  10. 10.
    Ando A, Nitta K, Ando I, et al. Mechanism of gallium 67 accumulation in inflammatory tissue. Eur J Nucl Med 1990;17(1-2):21-7.PubMedCrossRefGoogle Scholar
  11. 11.
    Nishiyama Y, Yamamoto Y, Fukunaga K, et al. Comparative evaluation of 18F-FDG PET and 67 Ga scintigraphy in patients with sarcoidosis. J Nucl Med 2006;47(10):1571-6.PubMedGoogle Scholar
  12. 12.
    Kaneta T, Hakamatsuka T, Takanami K, et al. Evaluation of the relationship between physiological FDG uptake in the heart and age, blood glucose level, fasting period, and hospitalization. Ann Nucl Med 2006;20(3):203-8.PubMedCrossRefGoogle Scholar
  13. 13.
    Israel O, Weiler-Sagie M, Rispler S, et al. PET-CT quantitation of the effect of patient-related factors on cardiac 18F-FDG uptake. J Nucl Med 2007;48(2):234-9.PubMedGoogle Scholar
  14. 14.
    Ng CK, Soufer R, McNulty PH. Effect of hyperinsulinemia on myocardial fluorine-18-FDG uptake. J Nucl Med 1998;39(3):379-83.PubMedGoogle Scholar
  15. 15.
    Wisneski JA, Gertz EW, Neese RA, Gruenke LD, Morris DL, Craig JC. Metabolic fate of extracted glucose in normal human myocardium. J Clin Invest 1985;76(5):1819-27.PubMedCrossRefGoogle Scholar
  16. 16.
    Williams G, Kolodny GM. Suppression of myocardial 18F-FDG uptake by preparing patients with a high-fat, low-carbohydrate diet. AJR Am J Roentgenol 2008;190(2):W151-6.PubMedCrossRefGoogle Scholar
  17. 17.
    Smedema JP, Snoep G, van Kroonenburgh MP, et al. The additional value of gadolinium-enhanced MRI to standard assessment for cardiac involvement in patients with pulmonary sarcoidosis. Chest 2005;128(3):1629-37.PubMedCrossRefGoogle Scholar
  18. 18.
    Vignaux O, Dhote R, Duboc D, et al. Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: A 1-year follow-up study. Chest 2002;122(6):1895-901.PubMedCrossRefGoogle Scholar
  19. 19.
    Ishimaru S, Tsujino I, Takei T, et al. Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis. Eur Heart J 2005;26(15):1538-43. Epub 2005 Apr 4.PubMedCrossRefGoogle Scholar

Copyright information

© American Society of Nuclear Cardiology 2009

Authors and Affiliations

  • Rumman Langah
    • 1
  • Kenneth Spicer
    • 1
  • Mulugeta Gebregziabher
    • 2
  • Leonie Gordon
    • 1
  1. 1.Department of Nuclear MedicineMedical University of South CarolinaCharlestonUSA
  2. 2.Department of Biostatistics, Bioinformatics and EpidemiologyMedical University of South CarolinaCharlestonUSA

Personalised recommendations